Medical treatment of noncicatricial alopecia.
Study Design
- 研究タイプ
- narrative review
- 介入
- Medical treatment of noncicatricial alopecia. varies by treatment
- 比較対照
- Placebo
- 効果の方向
- Positive
- バイアスリスク
- Unclear
Abstract
Androgenetic alopecia, alopecia areata, and telogen effluvium are the primary nonscarring alopecias found in clinical practice. Androgenetic alopecia is considered to be the most common form of human alopecia and is postulated to affect more than 50% of men by age 50. Alopecia areata affects up to 2% of the U.S. population. Telogen effluvium frequently occurs after major life events, such as a severe illness, childbirth, or high fever, and may be associated with the use of certain medications or iron deficiency, particularly in women. The focus of this review is on the medical treatment of these common hair loss conditions.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
The Journal of investigative dermatology · 2003
Decreased serum ferritin is associated with alopecia in women.
Pediatrics · 2012
The diet factor in attention-deficit/hyperactivity disorder.
Journal of clinical and diagnostic research : JCDR · 2015
Telogen Effluvium: A Review.
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
Sleep medicine clinics · 2015